化合物 T15345 T15345
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
100 mg | 189699-82-9 | ¥19,500.00 | 询底价 |
25 mg | 189699-82-9 | ¥11,700.00 | 询底价 |
50 mg | 189699-82-9 | ¥15,300.00 | 询底价 |
Product Introduction
Bioactivity
英文名: FR-188582
描述: FR-188582 is a highly selective cyclooxygenase (COX)-2 inhibitor (IC50: 17 nM).
体外活性: FR-188582 inhibits COX-2 (IC50: 17 nM), in a recombinant human COX enzyme activity. The inhibition of prostaglandin (PG) E2 formation by FR188582 is over 6000 times more selective for COX-2 than COX-1.
体内活性: FR-188582 (0.01-3.2 mg/kg, p.o.) reverses paw edema in adjuvant arthritic rats and displays a therapeutic effect in a dose-dependent manner. For adjuvant-injected paws and adjuvant-uninjected paws, the ED50s values (95% C.L.) are 0.074 (0.00021-0.53) and 0.063 (0.0039-0.31) mg/kg , respectively. The anti-inflammatory effect of FR-188582 is threefold more potent than that of Indomethacin. For adjuvant-injected paws and adjuvant-uninjected paws, the ED50s values (95% C.L.) are 0.24 (0.047-1.8) and 0.20 (0.021-0.79) mg/kg, respectively.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
关键字: FR-188582 | FR 188582 | FR188582
相关产品: (S)-(+)-Ibuprofen D3 | Ginsenoside Rg5 | Guaiacol | Indomethacin | Rebamipide | Bufexamac | Aspirin | Indobufen | FR 122047 | Zedoarondiol
化合物 T15345 T15345信息由TargetMol中国为您提供,如您想了解更多关于化合物 T15345 T15345报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途